Showing results (91-100 of 108) with videos related to
Sort By:
Pageof 11
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 21, 2015
A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical StudiesAnke Post, Trevor S Smart, Judith Krikke-Workel, et al.The Lancet Regional Health. Europe|December 3, 2025
Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation: economic evaluation of the PAX-D randomised controlled trialAgata Łaszewska, Timea Helter, Ashley Baldwin, et al.Journal of Global Health|December 6, 2022
Setting national research priorities for difficult-to-treat depression in the UK between 2021-2026Natalya Chapman, Michael Browning, David Baghurst, et al.Wellcome Open Research|July 19, 2024
Pro-dopaminergic pharmacological interventions for anhedonia in depression: protocol for a living systematic review of human and non-human studiesEdoardo G Ostinelli, Virginia Chiocchia, Malcolm Macleod, et al.Brain : a Journal of Neurology|September 18, 2025
Reduced striatal dopamine transmission as a transdiagnostic substrate of psychomotor retardationIan Lam Leong, Tsz Huen Ng, Kunal Sen, et al.Schizophrenia (Heidelberg, Germany)|August 7, 2023
Effects of ulotaront on brain circuits of reward, working memory, and emotion processing in healthy volunteers with high or low schizotypyFrancesca Perini, Jadwiga Maria Nazimek, Shane Mckie, et al.BMC Psychiatry|November 16, 2023
Cognitive Remediation in Bipolar (CRiB2): study protocol for a randomised controlled trial assessing efficacy and mechanisms of cognitive remediation therapy compared to treatment as usualDimosthenis Tsapekos, Rebecca Strawbridge, Matteo Cella, et al.Bjpsych Open|April 13, 2026
The cost-effectiveness of predictive algorithm guided primary antidepressant treatment: economic evaluation of the multinational PReDicT randomised controlled trialNataša Perić, Susanne Mayer, Timea Helter, et al.Orphanet Journal of Rare Diseases|August 4, 2016
Primary immunodeficiency associated with chromosomal aberration - an ESID surveyEllen Schatorjé, Michiel van der Flier, Mikko Seppänen, et al.Ebiomedicine|October 30, 2025
Pro-dopaminergic pharmacological interventions for anhedonia in depression: a living systematic review and network meta-analysis of human and animal studiesEdoardo G Ostinelli, Georgia Salanti, Malcolm Macleod, et al.Pageof 11